Shenzhen New Industries Biomedical Engineering Co Ltd SZSE:300832:
Q3 NET PROFIT DOWN 9.7% Y/Y
New Industries Biomedical Q3 Net Profit Down 9.7% Y/Y
Earlier from Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A
- Shenzhen New Industries Biomedical Engineering Co: H1 2025 revenue fell 1.18% to ¥2.18B, net profit down 14.62%, overseas sales up 19.57%
- Shenzhen New Industries Biomedical Engineering Co: 2024 revenue up 15.41%, net profit up 10.57%, strong global growth and high dividend
- Shenzhen New Industries Biomedical Engineering Co: Double-digit revenue and profit growth, led by robust overseas expansion and innovation
- Shenzhen New Industries Biomedical Engineering Co: Q3 revenue and profit rose double digits year-over-year, driven by strong product and market growth